1. A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers. (18th August 2021) Authors: Cercek, Andrea; Chatila, Walid K; Yaeger, Rona; Walch, Henry; Fernandes, Gustavo Dos Santos; Krishnan, Asha; Palmaira, Lerie; Maio, Anna; Kemel, Yelena; Srinivasan, Preethi; Bandlamudi, Chaitanya; Salo-Mullen, Erin; Tejada, Prince R; Belanfanti, Kimeisha; Galle, Jesse; Joseph, Vijai; Segal, Neil;... Journal: Journal of the National Cancer Institute Issue: Volume 113:Number 12(2021) Page Start: 1683 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial. Issue 6 (June 2020) Authors: Janjigian, Yelena Y; Maron, Steven B; Chatila, Walid K; Millang, Brittanie; Chavan, Shweta S; Alterman, Carly; Chou, Joanne F; Segal, Michal F; Simmons, Marc Z; Momtaz, Parisa; Shcherba, Marina; Ku, Geoffrey Y; Zervoudakis, Alice; Won, Elizabeth S; Kelsen, David P; Ilson, David H; Nagy, Rebecca J... Journal: Lancet oncology Issue: Volume 21:Issue 6(2020) Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗